Providing a voice for Montana's multidisciplinary cancer care teams and the patients they serve since 2015

aacp hero banner

WELCOME

YELLOWSTONE 2025 BEST OF ASCO

YELLOWSTONE 2025 BEST OF ASCOREGISTER

ONCOLOGY NEWS

ONCOLOGY NEWS
FDA Approves Fruquintinib in Refractory Metastatic Colorectal Cancer
MORE ONCOLOGY NEWS

MEMBER BENEFIT

MEMBER BENEFITJOIN THE CONVERSATION

Have a question?
Feel free to contact us.

Contact Us

Get Connected

ASCO AffiliatesACCC eXchange ACCC

Copyright © Montana State Oncology Society. All rights reserved.

Privacy Policy